Yew Bio-Pharm Group, Inc. is a holding company, which engages in growing and selling yew trees, and manufacturing of products made from yew trees in China. It also sells raw material, including the branches and leaves of yew trees, used in the manufacture of traditional Chinese medicine. It operates through the PRC and USA geographical segments. The company was founded by Zhi Guo Wang in 1996 and is headquartered in El Monte, CA.
Company profile
Ticker
YEWB
Exchange
Website
CEO
Zhi Guo Wang
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Yew Bio-Pharm Holdings Limited • Heilongjiang Jinshangjing Bio-Technology Development Co., Limited • Harbin Yew Science and Technology Development Co., Ltd. • Harbin Yew Food Co. Ltd. • MC Commerce Holding Inc. • Harbin Jingchibai Bio-Technology Development Co., Limited • Yew (Guangzhou) Bio-Technology Co., Ltd ...
YEWB stock data
Latest filings (excl ownership)
REVOKED
Registration or securities revoked
9 Nov 23
8-K
Departure of Directors or Certain Officers
29 Mar 22
DEFA14C
Additional information
29 Nov 21
DEF 14C
Information statement
29 Nov 21
10-Q
2021 Q3
Quarterly report
15 Nov 21
PRE 14C
Preliminary information
15 Nov 21
10-Q
2021 Q2
Quarterly report
16 Aug 21
8-K
Departure of Directors or Certain Officers
27 Jul 21
10-Q
2021 Q1
Quarterly report
17 May 21
10-K
2020 FY
Annual report
30 Mar 21
Financial summary
Quarter (USD) | Sep 21 | Jun 21 | Mar 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 28.45 k | 28.45 k | 28.45 k | 28.45 k | 28.45 k | 28.45 k |
Cash burn (monthly) | 46.16 k | 99.65 k | 519.56 k | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 1.38 mm | 2.99 mm | 15.58 mm | n/a | n/a | n/a |
Cash remaining | -1.36 mm | -2.96 mm | -15.55 mm | n/a | n/a | n/a |
Runway (months of cash) | -29.4 | -29.7 | -29.9 | n/a | n/a | n/a |